Das et al., 2021 - Google Patents
Are we ready for covid–19 vaccines?–A general side effects overviewDas et al., 2021
View PDF- Document ID
- 8985097975914089659
- Author
- Das L
- Meghana A
- Paul P
- Ghosh S
- Publication year
- Publication venue
- Journal of Current Medical Research and Opinion
External Links
Snippet
A vaccine is considered to be one of the best options in public health safety, specifically when there is no effective vaccine available against that infectious disease. 6 Classic vaccine development often takes years, but developing a vaccine for the prevention of Covid …
- 229940022962 COVID-19 vaccine 0 title abstract description 37
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ivers et al. | COVID-19: global health equity in pandemic response | |
Riva et al. | Pandemic fear and literature: observations from Jack London’s The Scarlet Plague | |
Casadevall et al. | SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities | |
Fauci | Emerging and reemerging infectious diseases: the perpetual challenge | |
Stern et al. | The history of vaccines and immunization: familiar patterns, new challenges | |
Jogalekar et al. | Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions | |
Bitanihirwe | Monitoring and managing mental health in the wake of Ebola | |
Kirenga et al. | Efficacy of convalescent plasma for treatment of COVID-19 in Uganda | |
Das et al. | Are we ready for covid–19 vaccines?–A general side effects overview | |
Ambrose et al. | An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years | |
Bearden et al. | An outbreak of the 2009 influenza a (H1N1) virus in a children’s hospital | |
Juan-Giner et al. | Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial | |
Koch | Ebola, quarantine, and the scale of ethics | |
Tweed et al. | Syndemic health crises—The growing role of National Public Health Institutes in shaping a coordinated response | |
Guharoy et al. | Smallpox: clinical features, prevention, and management | |
Bouare et al. | COVID-19: A pluralistic and integrated approach for efficient management of the pandemic | |
Hutchinson et al. | COVID-19 Variants of Concern in Australia, September 2020-April 2021. | |
Afolabi | Vaccination | |
Boushab et al. | Two cases of delayed diagnosis of leprosy in Mauritania | |
Sevak et al. | Review of novel corona virus disease (Covid-19) in India | |
Sah et al. | Re-emergence of Sudan ebolavirus after a decade: new challenge to Ebola control | |
Escott et al. | Don't forget the bigger picture: The impact of societal issues on a community‐based TB programme, Swaziland | |
Akech et al. | COVID-19 Vaccination Uptake and Self-Reported Side Effects among Healthcare Workers in Mbale City Eastern Uganda | |
Marcus et al. | Vaccination During the COVID-19 Pandemic: What Nurses Need To Know. | |
Datta et al. | Randomization amid a pandemic–a critical appraisal regarding convalescent plasma therapy clinical trials for COVID‐19 patients |